AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,009,033 | -12.1% | 40,769 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,148,036 | -19.6% | 40,538 | -34.8% | 0.00% | -50.0% |
| Q1 2023 | $1,427,126 | -18.5% | 62,130 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $1,751,181 | -0.7% | 62,364 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $1,763,654 | +267.4% | 62,364 | +188.3% | 0.00% | +200.0% |
| Q2 2022 | $480,000 | -25.3% | 21,634 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $643,000 | -11.4% | 22,095 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $726,000 | -32.3% | 22,095 | -4.9% | 0.00% | -50.0% |
| Q3 2021 | $1,072,000 | -19.3% | 23,227 | -3.7% | 0.00% | -33.3% |
| Q2 2021 | $1,329,000 | +159.6% | 24,116 | +143.1% | 0.00% | +200.0% |
| Q1 2021 | $512,000 | +14.8% | 9,921 | -3.6% | 0.00% | 0.0% |
| Q4 2020 | $446,000 | +16.4% | 10,289 | -6.0% | 0.00% | 0.0% |
| Q3 2020 | $383,000 | -35.8% | 10,951 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $597,000 | +41.5% | 11,171 | -6.1% | 0.00% | 0.0% |
| Q1 2020 | $422,000 | -25.2% | 11,894 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $564,000 | +79.6% | 11,804 | +21.9% | 0.00% | 0.0% |
| Q3 2019 | $314,000 | -35.1% | 9,687 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $484,000 | -50.3% | 9,697 | -32.9% | 0.00% | -50.0% |
| Q1 2019 | $974,000 | +38.2% | 14,448 | -5.6% | 0.00% | 0.0% |
| Q4 2018 | $705,000 | -40.1% | 15,297 | +0.3% | 0.00% | 0.0% |
| Q3 2018 | $1,176,000 | -10.4% | 15,244 | -2.1% | 0.00% | -33.3% |
| Q2 2018 | $1,312,000 | -8.4% | 15,575 | -11.1% | 0.00% | 0.0% |
| Q1 2018 | $1,433,000 | +68.4% | 17,525 | +17.7% | 0.00% | +50.0% |
| Q4 2017 | $851,000 | -18.0% | 14,886 | -4.3% | 0.00% | 0.0% |
| Q3 2017 | $1,038,000 | +28.6% | 15,557 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $807,000 | +9.3% | 15,687 | +24.2% | 0.00% | 0.0% |
| Q1 2017 | $738,000 | +33.9% | 12,632 | -4.4% | 0.00% | +100.0% |
| Q4 2016 | $551,000 | -24.4% | 13,214 | -4.2% | 0.00% | 0.0% |
| Q3 2016 | $729,000 | +41.3% | 13,794 | +12.1% | 0.00% | 0.0% |
| Q2 2016 | $516,000 | +12.2% | 12,310 | +8.6% | 0.00% | 0.0% |
| Q1 2016 | $460,000 | -38.1% | 11,334 | -0.9% | 0.00% | -50.0% |
| Q4 2015 | $743,000 | -10.3% | 11,439 | -2.5% | 0.00% | 0.0% |
| Q3 2015 | $828,000 | -37.3% | 11,728 | -1.3% | 0.00% | -33.3% |
| Q2 2015 | $1,321,000 | +84.0% | 11,888 | +56.1% | 0.00% | +50.0% |
| Q1 2015 | $718,000 | -15.8% | 7,616 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $853,000 | +82.7% | 7,616 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $467,000 | +33.8% | 7,616 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $349,000 | – | 7,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |